Science has always moved slowly. Most experiments fail. Most hypotheses
never get tested. The reason isn't lack of ideas. It's lack of time. AI
scientific discovery is now changing that reality, and Lila Sciences is at
the center of it.
Founded in 2023, Lila Sciences spent two years building quietly in
Cambridge, Massachusetts. Then, in March 2025, it stepped out of stealth with
$200 million already raised and thousands of discoveries already made. It
didn't just announce itself. It arrived with proof.
However, the story isn't just about one company. It's about what happens
when AI stops assisting scientists and starts doing science on its own.
Traditional research follows a slow loop. A scientist forms a hypothesis,
designs an experiment, waits for results, and starts over. Each cycle takes
days or weeks. In contrast, Lila's platform closes that loop in hours.
Lila calls its facilities AI Science Factories. These are physical labs
where AI, software, and robotics work together. The system generates
hypotheses, designs experiments, runs them, and learns from every result.
Therefore, each new experiment makes the system smarter than the last. Geoffrey
von Maltzahn, co-founder and CEO, describes it simply: the AI is the brain, and
the factories are the body. Together, they run the full scientific method
without stopping.
So what does this actually look like in practice? In drug development,
Lila's agents design and test novel proteins, antibodies, and nucleic acids.
According to the company, workflows that once took human teams days now
complete in minutes or hours.
In addition, Lila applies the same approach to materials science, clean
energy, and aerospace. For example, in energy research, it searches for new
fuels and cleaner catalysts. In advanced materials, it identifies ultra-stable
metals and coatings for extreme environments. Consequently, Lila doesn't target
one industry. Instead, it serves any field where breakthrough science is slow
and costly.
The results speak clearly. In October 2025, Lila closed a $350 million
Series A, bringing total funding to $550 million and pushing its valuation
above $1.3 billion. NVIDIA's venture arm NVentures joined the round, alongside
the CIA's In-Q-Tel, General Catalyst, and the Abu Dhabi Investment Authority.
Moreover, in March 2026, Fast Company named Lila one of the Top 10 Most
Innovative AI Companies of 2026.
That recognition confirms that AI scientific discovery is no
longer a theory. It's a working platform with real customers and real results.
Most scientific fields remain siloed. Chemistry doesn't talk to biology.
Materials science rarely overlaps with drug design. However, Lila's platform
runs across all of them simultaneously. A single AI model, trained on hundreds
of thousands of real experiments, spots patterns across domains that no human
team could connect alone.
This matters especially for global challenges. Climate change, disease,
and energy scarcity all demand faster answers than traditional labs can
provide. Traditional research moves one experiment at a time. Lila Sciences
runs thousands in parallel. The next breakthrough in AI scientific discovery
may not come from a single moment of inspiration. It may come from a machine
that simply never stops asking questions.
Please subscribe to have unlimited access to our innovations.